houseoffunfreecoinsandspins2018| *ST Target Pharmaceutical: The wholly-owned subsidiary plans to implement 100 million yuan capacity improvement and technological transformation projects

News summary

[ST Target Pharmaceutical: The wholly-owned subsidiary plans to implement 100 million yuan capacity improvement and technological transformation projects] Securities Times e Company Newshouseoffunfreecoinsandspins2018*ST Eye Pharmaceutical (600671) announced on the evening of May 23 that its wholly-owned subsidiary Huangshan Tianmu plans to invest approximately 100 million yuan to build a new production workshop in the existing factory area and optimize and transform the original productionhouseoffunfreecoinsandspins2018.houseoffunfreecoinsandspins2018..

Newsletter text

[ST Target Pharmaceutical: The wholly-owned subsidiary plans to implement 100 million yuan capacity improvement and technological transformation projects] Securities Times e Company News, *ST Target Pharmaceutical (600671) announced on the evening of May 23 that the wholly-owned subsidiary Huangshan Tianmu plans to invest about 100 million yuan, build new production workshops in the existing factory area, optimize and renovate the original production line, increase production capacity, build intelligent, digital and information-based factories, and become a market competitive factoryhouseoffunfreecoinsandspins2018A modern traditional Chinese medicine production enterprise.